Surmodics, Inc. announced the appointment of Timothy J. Arens, Vice President of Corporate Development and Strategy, as the company's Vice President, Finance and Chief Financial Officer and principal financial officer, effective immediately. Mr. Arens had served in this role on an interim basis since May 25, 2018. Mr. Arens will continue to serve as the company's Vice President, Corporate Development and Strategy, a role in which he has served since February 2013.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
34.38 USD | +0.47% | -0.69% | -5.42% |
05-02 | Barrington Ups Price Target on SurModics to $71 From $70, Maintains Outperform Rating | MT |
05-01 | Top Midday Gainers | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.42% | 490M | |
-5.56% | 181B | |
-0.11% | 108B | |
-6.17% | 66.12B | |
+2.64% | 50.65B | |
+6.58% | 43.66B | |
+4.91% | 41.3B | |
+21.98% | 31.6B | |
+14.45% | 25.03B | |
-5.81% | 24.16B |
- Stock Market
- Equities
- SRDX Stock
- News Surmodics, Inc.
- Surmodics, Inc. Appoints Timothy J. Arens as Vice President, Finance and Chief Financial Officer and Principal Financial Officer